DOCSLIB.ORG

Movement Disorders Emergencies Part 2 Hyperkinetic Disorders

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Movement Disorders Emergencies Part 2 Hyperkinetic Disorders NEUROLOGICAL REVIEW Movement Disorders Emergencies Part 2 Hyperkinetic Disorders Bradley J. Robottom, MD; Stewart A. Factor, DO; William J. Weiner, MD lthough movement disorders do not usually present as neurologic emergencies, there are times when the abrupt onset of an unusual movement abnormality results in emer- gency department or intensive care unit consultations. Part 1 of this review discussed hypokinetic movement disorders emergencies. Part 2 provides a diagnostic approach Ato the recognition and treatment of hyperkinetic movement disorders emergencies by identifying phenomenology and reviewing common etiologies. Arch Neurol. 2011;68(6):719-724 Movement disorders most often have an inflammatory disorders and may be acute insidious onset and a slowly progressive in onset. Sydenham chorea is the most com- course and are not associated with emer- mon cause of acquired, childhood-onset gency situations. In part 1, we addressed chorea.1 Sydenham chorea is the neuro- hypokinetic movement disorders emer- logic manifestation of rheumatic fever and gencies focusing on drug-induced emer- is sufficient to make the diagnosis of rheu- gencies and acute complications of Par- matic fever.2 Its incidence has declined dra- kinson disease. Part 2 focuses on the matically with the widespread availability phenomenology of hyperkinetic move- of penicillin; nevertheless, Sydenham cho- ment disorders (chorea, ballism, myoclo- rea remains prevalent in areas where ac- nus, and dystonia) as the key to appropri- cess to health care is limited.3,4 In addition ate recognition and treatment in the to chorea, which may be generalized or emergent situation. Key clinical features hemichorea, additional features of Syden- of hyperkinetic movement disorders are ham chorea include behavioral changes (ob- presented in Table 1. sessions, compulsions, hyperactivity, and emotional lability), weakness, hypotonia, HYPERKINETIC DISORDERS and, rarely, vocalizations.5 Symptoms may begin abruptly, from 1 to 6 months after Chorea streptococcal pharyngitis.6 The diagnosis is made clinically, though elevated antistrep- Chorea consists of involuntary, irregular, tolysin O antibody titers are supportive. purposeless movements that “flow” into one Treatment with penicillin may prevent the another in a random fashion. Though of- cardiac complications of rheumatic fever ten referred to separately, the distinction and is sometimes continued for several years between chorea, athetosis, ballismus, and as prophylaxis.7 If Sydenham chorea re- dystonia is somewhat arbitrary and relates quires treatment, 1 prospective, nonran- more to speed, amplitude, and duration of domized trial suggested that valproic acid the movement rather than underlying pa- or carbamazepine may be used.1 Based on thology. A combination of these move- observational data, dopamine receptor ments is often encountered in a single blockers or dopamine depleters are also rec- patient. Chorea may result from toxic/ ommended.8 metabolic, vascular, and infectious/ Chorea gravidarum usually begins in the first or early second trimester.9 Chorea may Author Affiliations: Department of Neurology, University of Maryland School of be unilateral or bilateral, often involving the Medicine, Baltimore (Drs Robottom and Weiner); and Movement Disorders face as well as the limbs. Dysarthria is com- Program, Emory University School of Medicine, Atlanta, Georgia (Dr Factor). mon.10 Chorea usually resolves by the third ARCH NEUROL / VOL 68 (NO. 6), JUNE 2011 WWW.ARCHNEUROL.COM 719 ©2011 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/26/2021 Table 1. Clinical Definitions of Hyperkinetic Table 2. Etiologies of Acute-Onset Chorea Movement Disorders Etiology Hyperkinetic Vascular Movement Disorder Clinical Definition Ischemic stroke Chorea Involuntary, irregular, purposeless movements Hemorrhagic stroke that “flow” into one another in a random Cavernous angioma fashion Cerebral anoxia Ballism Rapid, large-amplitude proximal movements Metabolic that are sometimes described as “flinging” Nonketotic hyperglycemia May be present with chorea, representing an Hypoglycemia extreme end of the spectrum of chorea Hyperthyroidism Myoclonus Sudden, brief shocklike movements Pregnancy May be due to muscle contraction (positive Structural myoclonus) or loss of muscle tone (negative Basal ganglia mass lesion myoclonus or asterixis) Cerebellar mass lesion Tics Brief, paroxysmal movements or vocalizations Thalamotomy or subthalamotomy sometimes accompanied by premonitory urge Inflammatory May be stereotyped Multiple sclerosis Unlike other hyperkinetic movements, may be Sarcoidosis voluntarily suppressed for a short period Infectious Dystonia Involuntary, sustained muscle contractions that Cryptococcal granuloma produce twisting or squeezing movements Toxoplasmosis Often accompanied by abnormal posture Tuberculoma Human immunodeficiency virus encephalitis Sydenham chorea trimester or disappears within hours after delivery.11 Al- Autoimmune though chorea gravidarum is rarely an emergency, it is likely Systemic lupus erythematosus Antiphospholipid antibody syndrome that neurologists will encounter this entity in the context Scleroderma of an emergent inpatient consultation on a maternity ward. Behc¸et disease The antiphospholipid syndrome may result in acute Iatrogenic generalized chorea. Antiphospholipid syndrome may be Anticonvulsants primary or secondary to systemic lupus erythematosus. Oral contraceptives Antiphospholipid syndrome is thought to be the most Levodopa common cause of chorea gravidarum in industrialized na- Cocaine 12 Amphetamines tions. Rarely is chorea the sole manifestation of an- Alchohol, intoxication and withdrawal tiphospholipid syndrome, but a high index of suspicion is important because of the other potentially cata- strophic manifestations (eg, deep venous thrombosis, pul- (Figure 1). Magnetic resonance imaging findings re- monary emboli, stroke, thrombotic microangiopathy, sult from ischemic injury due to hyperviscosity and re- thrombocytopenia, and hemolytic anemia) that could oc- gional metabolic failure. Like hemiballism secondary to cur with failure to diagnose and treat antiphospholipid stroke, the movements typically subside over a period of syndrome.12 Other metabolic causes include hyperthy- months. In some patients, abnormal movements re- roidism and hyperglycemia (Table 2). verse when the glucose level is normalized. Resolution of magnetic resonance imaging signal change correlates Hemichorea-Hemiballism with clinical improvement in chorea.17 If treatment is re- quired (eg, violent, self-injurious, exhausting, or dis- Hemiballism refers to large-amplitude, flinging move- tressing movements), dopamine receptor blockers or ments of one side of the body that can be violent. As hemi- dopamine depleters such as tetrabenazine or reserpine ballismus resolves over days to weeks, the movements are used (Table 3). Because the movements usually re- often become choreiform. Historically, the most com- solve over time,18 medication should be tapered after 3 mon cause of hemiballism was stroke involving the sub- months and the patient, reevaluated. thalamic nucleus. However, this etiology is rare, with an annual incidence of less than 1 per 100 000 in a popu- Myoclonus lation-based study from Belgrade, Serbia.13 Although stroke remains the most common cause, only a minor- Myoclonus consists of sudden, brief shocklike move- ity of cases have lesions within the contralateral subtha- ments that may be due to muscle contraction (positive lamic nucleus.14-16 The second most commonly re- myoclonus) or loss of muscle tone (negative myoclonus ported cause of hemiballism is nonketotic hyperglycemia. or asterixis). Neurologists are often emergently con- With this disorder, chorea, or ballism, may be unilateral sulted in the intensive care unit to see patients with my- or bilateral. It occurs more in women,17 and it may be oclonus as a result of toxic/metabolic derangements or the initial presentation of diabetes mellitus. Magnetic reso- cerebral anoxia. It is also seen in serotonin syndrome and nance T1-weighted images demonstrate hyperintensity neuroleptic malignant syndrome. Medications includ- in the putamen, caudate nucleus, and globus pallidus17 ing monoamine oxidase inhibitors, selective serotonin ARCH NEUROL / VOL 68 (NO. 6), JUNE 2011 WWW.ARCHNEUROL.COM 720 ©2011 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/26/2021 reuptake inhibitors, serotonin-norepinephrine reup- lenting, generalized multifocal myoclonus involving the face, take inhibitors, tricyclic antidepressants, opiates, le- limbs, and axial musculature in comatose patients,” is omi- vodopa, gabapentin, triptans, lysergic acid diethylam- nous.22 The chance of good recovery in this setting is ex- ide (LSD), amphetamines, cocaine, and 3,4- ceedingly low,23 and the likelihood of any outcome other methylenedioxymethamphetamine (MDMA or ecstasy) than a poor one is 0% (95% confidence interval, 0%-8.8%).22 may cause myoclonus. Hepatic and uremic encephalopa- A “poor outcome” is defined as death or persisting uncon- thies are the most common metabolic derangements re- sciousness after 1 month or death, persisting unconscious- sulting in myoclonus and asterixis.19,20 ness, or severe disability requiring full nursing care after 6 Cerebral anoxia may result in 2 distinct myoclonic syn- months. Postanoxic myoclonus (Lance-Adams syn- dromes, myoclonus status epilepticus
Load more

Recommended publications
  • A Case with Dyskinesia Induced by Pramipexole, Pregabalin And
    DO I:10.4274/Tnd.63497 Case Report / Olgu Sunumu A Case with Dyskinesia Induced by Pramipexole, Pregabalin and Gabapentin After Cardiopulmonary Resuscitation Kardiyopulmoner Resusitasyon Sonrası Pramipeksol, Pregabalin ve Gabapentin Kullanımının Tetiklediği Diskinezi Olgusu Dürdane Aksoy, Betül Çevik, Volkan Solmaz, Semiha Gülsüm Kurt, Orhan Sümbül Gaziosmanpaşa University School of Medicine, Department of Neurology, Tokat, Turkey Sum mary Drug-induced dyskinesias can be seen occasionally in clinical practice. Here we present a 70-year-old patient who developed a noticeable dyskinesia after the use of pramipexole, gabapentin, pregabalin respectively for his restless leg syndrome. Prior to this condition, he was hospitalized in intensive care unit for the myocardial infarction that required cardiopulmonary resuscitation, and he was discharged with no neurological deficits. The case presented here is a good example indicating the importance of being vigilant for drug-induced dyskinesias after hypoxic-ischemic encephalopathy, even though everything else seems right. (Turkish Journal of Neurology 2013; 19:148-150) Key Words: Hypoxic-ischemic encephalopathy, dyskinesia, pramipexole, gabapentin, pregabalin Özet İlaç kullanımı sonrasında ortaya çıkan hareket bozuklukları klinik pratikte zaman zaman karşılaştığımız sorunlardır. Burada kardiyopulmoner resüsitasyon gerektiren bir miyokard enfarktüsünün ardından bir süre yoğun bakımda kalan, nörolojik defisiti kalmadan iyileşen ancak daha sonra huzursuz bacak sendromu tedavisi için başlanan pramipeksol,
    [Show full text]
  • Physiology of Basal Ganglia Disorders: an Overview
    LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES SILVERSIDES LECTURE Physiology of Basal Ganglia Disorders: An Overview Mark Hallett ABSTRACT: The pathophysiology of the movement disorders arising from basal ganglia disorders has been uncer­ tain, in part because of a lack of a good theory of how the basal ganglia contribute to normal voluntary movement. An hypothesis for basal ganglia function is proposed here based on recent advances in anatomy and physiology. Briefly, the model proposes that the purpose of the basal ganglia circuits is to select and inhibit specific motor synergies to carry out a desired action. The direct pathway is to select and the indirect pathway is to inhibit these synergies. The clinical and physiological features of Parkinson's disease, L-DOPA dyskinesias, Huntington's disease, dystonia and tic are reviewed. An explanation of these features is put forward based upon the model. RESUME: La physiologie des affections du noyau lenticulaire, du noyau caude, de I'avant-mur et du noyau amygdalien. La pathophysiologie des desordres du mouvement resultant d'affections du noyau lenticulaire, du noyau caude, de l'avant-mur et du noyau amygdalien est demeuree incertaine, en partie parce qu'il n'existe pas de bonne theorie expliquant le role de ces structures anatomiques dans le controle du mouvement volontaire normal. Nous proposons ici une hypothese sur leur fonction basee sur des progres recents en anatomie et en physiologie. En resume, le modele pro­ pose que leurs circuits ont pour fonction de selectionner et d'inhiber des synergies motrices specifiques pour ex£cuter Taction desiree. La voie directe est de selectionner et la voie indirecte est d'inhiber ces synergies.
    [Show full text]
  • Oral Contraceptive Induced Chorea: Another Condition Associated with Anti-Basal Ganglia Antibodies M Miranda, F Cardoso, G Giovannoni, a Church
    327 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.2003.019851 on 23 January 2004. Downloaded from SHORT REPORT Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies M Miranda, F Cardoso, G Giovannoni, A Church ............................................................................................................................... J Neurol Neurosurg Psychiatry 2004;75:327–328 anti-DNAase B titre of 120 IU/ml was normal (normal Use of oral contraceptives is a recognised but infrequent ,340 IU/ml). Throat cultures did not detect streptococcus. cause of chorea. This type of chorea has usually been Her full blood count, erythrocyte sedimentation rate, C- considered a reactivation of Sydenham’s chorea by an reactive protein, thyroid function, plasma amino acids, unknown mechanism. A patient developed a chorea ceruloplasmin, antinuclear antibodies, and antiphospholipid triggered by the use of oral contraceptives with no definite antibodies were either normal or negative. Magnetic reson- evidence of previous Sydenham’s chorea or recent streptoc- ance imaging of the brain was normal. Echocardiogram cocal infections. However, the patient had positive anti-basal showed no alterations. Anti-basal ganglia antibodies were ganglia antibodies, which supports an immunological basis positive by Western immunoblotting and revealed reactivity for the pathophysiology of this chorea. against antigens of 40 and 45 kDa in size. The antibody assay method has been described previously.4 The patient’s serum was also screened against a liver antigen preparation to exclude non-specific binding as a result of antinuclear factors or other auto-antibodies. These specific 40 and 45 kDa bands se of oral contraceptives is a well known but appear to be relatively specific for the group of disorders 12 uncommon cause of chorea .
    [Show full text]
  • Drug-Induced Movement Disorders
    Expert Opinion on Drug Safety ISSN: 1474-0338 (Print) 1744-764X (Online) Journal homepage: https://www.tandfonline.com/loi/ieds20 Drug-induced movement disorders Dénes Zádori, Gábor Veres, Levente Szalárdy, Péter Klivényi & László Vécsei To cite this article: Dénes Zádori, Gábor Veres, Levente Szalárdy, Péter Klivényi & László Vécsei (2015) Drug-induced movement disorders, Expert Opinion on Drug Safety, 14:6, 877-890, DOI: 10.1517/14740338.2015.1032244 To link to this article: https://doi.org/10.1517/14740338.2015.1032244 Published online: 16 May 2015. Submit your article to this journal Article views: 544 View Crossmark data Citing articles: 4 View citing articles Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ieds20 Review Drug-induced movement disorders Denes Za´dori, Ga´bor Veres, Levente Szala´rdy, Peter Klivenyi & † 1. Introduction La´szlo´ Vecsei † University of Szeged, Albert Szent-Gyorgyi€ Clinical Center, Department of Neurology, Faculty of 2. Methods Medicine, Szeged, Hungary 3. Drug-induced movement disorders Introduction: Drug-induced movement disorders (DIMDs) can be elicited by 4. Conclusions several kinds of pharmaceutical agents. The major groups of offending drugs include antidepressants, antipsychotics, antiepileptics, antimicrobials, antiar- 5. Expert opinion rhythmics, mood stabilisers and gastrointestinal drugs among others. Areas covered: This paper reviews literature covering each movement disor- der induced by commercially available pharmaceuticals. Considering the mag- nitude of the topic, only the most prominent examples of offending agents were reported in each paragraph paying a special attention to the brief description of the pathomechanism and therapeutic options if available. Expert opinion: As the treatment of some DIMDs is quite challenging, a pre- ventive approach is preferable.
    [Show full text]
  • Clinical Rating Scale for Pantothenate Kinase-Associated Neurodegeneration: a Pilot Study
    RESEARCH ARTICLE Clinical Rating Scale for Pantothenate Kinase-Associated Neurodegeneration: A Pilot Study Alejandra Darling, MD,1 Cristina Tello, PhD,2 Marı´a Josep Martı´, MD, PhD,3 Cristina Garrido, MD,4 Sergio Aguilera-Albesa, MD, PhD,5 Miguel Tomas Vila, MD,6 Itziar Gaston, MD,7 Marcos Madruga, MD,8 Luis Gonzalez Gutierrez, MD,9 Julio Ramos Lizana, MD,10 Montserrat Pujol, MD,11 Tania Gavilan Iglesias, MD,12 Kylee Tustin,13 Jean Pierre Lin, MD, PhD,13 Giovanna Zorzi, MD, PhD,14 Nardo Nardocci, MD, PhD,14 Loreto Martorell, PhD,15 Gustavo Lorenzo Sanz, MD,16 Fuencisla Gutierrez, MD,17 Pedro J. Garcı´a, MD,18 Lidia Vela, MD,19 Carlos Hernandez Lahoz, MD,20 Juan Darı´o Ortigoza Escobar, MD,1 Laura Martı´ Sanchez, 1 Fradique Moreira, MD ,21 Miguel Coelho, MD,22 Leonor Correia Guedes,23 Ana Castro Caldas, MD,24 Joaquim Ferreira, MD,22,23 Paula Pires, MD,24 Cristina Costa, MD,25 Paulo Rego, MD,26 Marina Magalhaes,~ MD,27 Marı´a Stamelou, MD,28,29 Daniel Cuadras Palleja, MD,30 Carmen Rodrı´guez-Blazquez, PhD,31 Pablo Martı´nez-Martı´n, MD, PhD,31 Vincenzo Lupo, PhD,2 Leonidas Stefanis, MD,28 Roser Pons, MD,32 Carmen Espinos, PhD,2 Teresa Temudo, MD, PhD,4 and Belen Perez Duenas,~ MD, PhD1,33* 1Unit of Pediatric Movement Disorders, Hospital Sant Joan de Deu, Barcelona, Spain 2Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigacion Prı´ncipe Felipe, Valencia, Spain 3Neurology Department, Hospital Clı´nic de Barcelona, Institut d’Investigacions Biomediques IDIBAPS.
    [Show full text]
  • Dystonia and Chorea in Acquired Systemic Disorders
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.65.4.436 on 1 October 1998. Downloaded from 436 J Neurol Neurosurg Psychiatry 1998;65:436–445 NEUROLOGY AND MEDICINE Dystonia and chorea in acquired systemic disorders Jina L Janavs, Michael J AminoV Dystonia and chorea are uncommon abnormal Associated neurotransmitter abnormalities in- movements which can be seen in a wide array clude deficient striatal GABA-ergic function of disorders. One quarter of dystonias and and striatal cholinergic interneuron activity, essentially all choreas are symptomatic or and dopaminergic hyperactivity in the nigros- secondary, the underlying cause being an iden- triatal pathway. Dystonia has been correlated tifiable neurodegenerative disorder, hereditary with lesions of the contralateral putamen, metabolic defect, or acquired systemic medical external globus pallidus, posterior and poste- disorder. Dystonia and chorea associated with rior lateral thalamus, red nucleus, or subtha- neurodegenerative or heritable metabolic dis- lamic nucleus, or a combination of these struc- orders have been reviewed frequently.1 Here we tures. The result is decreased activity in the review the underlying pathogenesis of chorea pathways from the medial pallidus to the and dystonia in acquired general medical ventral anterior and ventrolateral thalamus, disorders (table 1), and discuss diagnostic and and from the substantia nigra reticulata to the therapeutic approaches. The most common brainstem, culminating in cortical disinhibi- aetiologies are hypoxia-ischaemia and tion. Altered sensory input from the periphery 2–4 may also produce cortical motor overactivity medications. Infections and autoimmune 8 and metabolic disorders are less frequent and dystonia in some cases. To date, the causes. Not uncommonly, a given systemic dis- changes found in striatal neurotransmitter order may induce more than one type of dyski- concentrations in dystonia include an increase nesia by more than one mechanism.
    [Show full text]
  • Neurological Disorders in Liver Transplant Candidates: Pathophysiology ☆ and Clinical Assessment
    Transplantation Reviews 31 (2017) 193–206 Contents lists available at ScienceDirect Transplantation Reviews journal homepage: www.elsevier.com/locate/trre Neurological disorders in liver transplant candidates: Pathophysiology ☆ and clinical assessment Paolo Feltracco a,⁎, Annachiara Cagnin b, Cristiana Carollo a, Stefania Barbieri a, Carlo Ori a a Department of Medicine UO Anesthesia and Intensive Care, Padova University Hospital, Padova, Italy b Department of Neurosciences (DNS), University of Padova, Padova, Italy abstract Compromised liver function, as a consequence of acute liver insufficiency or severe chronic liver disease may be associated with various neurological syndromes, which involve both central and peripheral nervous system. Acute and severe hyperammoniemia inducing cellular metabolic alterations, prolonged state of “neuroinflamma- tion”, activation of brain microglia, accumulation of manganese and ammonia, and systemic inflammation are the main causative factors of brain damage in liver failure. The most widely recognized neurological complications of serious hepatocellular failure include hepatic encephalopathy, diffuse cerebral edema, Wilson disease, hepatic myelopathy, acquired hepatocerebral degeneration, cirrhosis-related Parkinsonism and osmotic demyelination syndrome. Neurological disorders affecting liver transplant candidates while in the waiting list may not only sig- nificantly influence preoperative morbidity and even mortality, but also represent important predictive factors for post-transplant neurological manifestations.
    [Show full text]
  • Acute and Chronic Chorea in Childhood Donald L
    Acute and Chronic Chorea in Childhood Donald L. Gilbert, MD, MS This review discusses diagnostic evaluation and management of chorea in childhood. Chorea is an involuntary, hyperkinetic movement disorder characterized by continuous, jerky, or flowing movement fragments, with irregular timing and direction. It tends to be enhanced by voluntary actions and generally causes interference with fine motor function. The diagnostic evaluation begins with accurate classification of the movement disorder followed by consideration of the time course. Most previously healthy children presenting with acute/subacute chorea have an autoimmune etiology. Chronic chorea usually occurs as part of encephalopathies or diseases causing more global neurologic symptoms. We review the management of acute/subacute and chronic choreas, with special emphasis on Sydenham chorea and benign hereditary chorea. Semin Pediatr Neurol 16:71–76 © 2009 Published by Elsevier Inc. horea is a nonpatterned, involuntary, hyperkinetic genetic chorea, will be emphasized. Paroxysmal movement Cmovement disorder. It is continuous, variable in speed, disorders involving chorea will not be discussed but are re- unpredictable in timing and direction, and flowing or jerky in viewed elsewhere.4 As the phenomenology of chorea over- appearance.1 Chorea may be accompanied by athetosis or laps in acute and chronic choreas, most features of the neu- ballism. Athetosis is also continuous but the rate is slower. rologic examination will be discussed under acute chorea. Athetosis often accompanies dystonia or occurs in symptom- atic chorea and may be referred to as choreoathetosis. Ballism designates larger amplitude, flinging, proximally generated Acute Chorea movements. It rarely occurs in isolation in children but can accompany chorea.
    [Show full text]
  • Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum
    International Journal of Environmental Research and Public Health Review Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum Hiroshi Mitoma 1,* , Mario Manto 2,3 and Aasef G. Shaikh 4 1 Medical Education Promotion Center, Tokyo Medical University, Tokyo 160-0023, Japan 2 Unité des Ataxies Cérébelleuses, Service de Neurologie, CHU-Charleroi, 6000 Charleroi, Belgium; [email protected] 3 Service des Neurosciences, University of Mons, 7000 Mons, Belgium 4 Louis Stokes Cleveland VA Medical Center, University Hospitals Cleveland Medical Center, Cleveland, OH 44022, USA; [email protected] * Correspondence: [email protected] Abstract: Ethanol consumption remains a major concern at a world scale in terms of transient or irreversible neurological consequences, with motor, cognitive, or social consequences. Cerebellum is particularly vulnerable to ethanol, both during development and at the adult stage. In adults, chronic alcoholism elicits, in particular, cerebellar vermis atrophy, the anterior lobe of the cerebellum being highly vulnerable. Alcohol-dependent patients develop gait ataxia and lower limb postural tremor. Prenatal exposure to ethanol causes fetal alcohol spectrum disorder (FASD), characterized by permanent congenital disabilities in both motor and cognitive domains, including deficits in general intelligence, attention, executive function, language, memory, visual perception, and commu- nication/social skills. Children with FASD show volume deficits in the anterior lobules related to sensorimotor functions (Lobules I, II, IV, V, and VI), and lobules related to cognitive functions (Crus II and Lobule VIIB). Various mechanisms underlie ethanol-induced cell death, with oxidative stress and Citation: Mitoma, H.; Manto, M.; Shaikh, A.G. Mechanisms of endoplasmic reticulum (ER) stress being the main pro-apoptotic mechanisms in alcohol abuse and Ethanol-Induced Cerebellar Ataxia: FASD.
    [Show full text]
  • D-Penicillamine-Induced Status Dystonicus in a Patient with Wilson’S Disease: a Diagnostic & Therapeutic Challenge
    A. Satyasrinivas, et al. D-penicillamine-induced Status Dystonicus | Case Report D-penicillamine-induced Status Dystonicus in A Patient with Wilson’s Disease: A Diagnostic & Therapeutic Challenge A. Satyasrinivas*, Y.S. Kanni, N.Rajesh, M.SaiSravanthi, Vijay kumar Department of General Medicine, Kamineni Institute Of Medical Sciences, Narketpally 508254 Andhra Pradesh, India. DOI Name http://dx.doi.org/10.3126/jaim.v3i2.14066 Keywords Dystonia,Gabapentin Kayser-Fleischer ring, ABSTRACT Trientein hydrochloride, Wilson’s disease. Wilson's disease is an autosomal-recessive disorder of copper metabolism Citation resulting from the absence or dysfunction of a copper-transporting protein. A. Satyasrinivas, Y.S. Kanni, N.Rajesh, The disease is mainly seen in children, adolescents and young adults, and is M.SaiSravanthi, Vijay kumar. D-penicillamine- induced Status Dystonicus in A Patient with characterized by hepatobiliary, neurologic, psychiatric and ophthalmologic Wilson’s Disease: A Diagnostic & Therapeutic (Kayser-Fleischer rings) manifestations. Mechanism of status dystonicus in WD Challenge. Journal of Advances in Internal Medicine is not clear We present here a case study of Wil. son’s disease in 14 year old 2014;03(01):62-64. child with dystonia not responed with routine therapy. INTRODUCTION but patient had developed loose stools, difficulty in speaking and pronouncing linguals. With these compliants he was Wilson’s disease (WD), also known as hepatolenticular admitted in the hospital. On Radio imaging and ophthalmic degeneration was first described in 1912 by Kinnear Wilson as examination he was diagnosed as a case of Wilson’s disease progressive lenticular degeneration. WD is an inherited, fatal and was started with tablet calcium Pantothenate and neurological disorder accompanied by chronic liver disease tablets D-Penicillamine and was discharged.
    [Show full text]
  • Radiologic-Clinical Correlation Hemiballismus
    Radiologic-Clinical Correlation Hemiballismus James M. Provenzale and Michael A. Schwarzschild From the Departments of Radiology (J.M.P.), Duke University Medical Center, Durham, and f'leurology (M.A.S.), Massachusetts General Hospital, Boston Clinical History derived from the Greek word meaning "to A 65-year-old recently retired surgeon in throw," because the typical involuntary good health developed disinhibited behavior movements of the affected limbs resemble over the course of a few months, followed by the motions of throwing ( 1) . Such move­ onset of unintentional, forceful flinging move­ ments usually involve one side of the body ments of his right arm and leg. Magnetic res­ (hemiballismus) but may involve one ex­ onance imaging demonstrated a 1-cm rim­ tremity (monoballism), both legs (parabal­ enhancing mass in the left subthalamic lism), or all the extremities (biballism) (2, 3). region, which was of high signal intensity on The motions are centered around the shoul­ T2-weighted images (Figs 1A-E). Positive der and hip joints and have a forceful, flinging serum human immunodeficiency virus anti­ quality. Usually either the arm or the leg is gen and antibody titers were found, with predominantly involved. Although at least mildly elevated cerebrospinal fluid toxo­ some volitional control over the affected plasma titers. Anti-toxoplasmosis treatment limbs is still maintained, the involuntary with sulfadiazine and pyrimethamine was be­ movements typically can be checked by the gun, with resolution of the hemiballistic patient for only a few moments ( 1). The movements within a few weeks and decrease movements are usually continuous but may in size of the lesion.
    [Show full text]
  • Wilson's Disease
    Reprinted with permission from Thieme Medical Publishers (Semin Neurol. 2007 April;27(2):123-132) Homepage at www.thieme.com Wilson’s Disease Ronald F. Pfeiffer, M.D.1 ABSTRACT Wilson’s disease is an autosomal-recessive disorder caused by mutation in the ATP7B gene, with resultant impairment of biliary excretion of copper. Subsequent copper accumulation, first in the liver but ultimately in the brain and other tissues, produces protean clinical manifestations that may include hepatic, neurological, psychiatric, oph- thalmological, and other derangements. Genetic testing is impractical because of the multitude of mutations that have been identified, so accurate diagnosis relies on judicious use of a battery of laboratory and other diagnostic tests. Lifelong palliative treatment with a growing stable of medications, or with liver transplantation if needed, can successfully ameliorate or prevent the progressive deterioration and eventual death that would otherwise inevitably ensue. This article discusses the epidemiology, genetics, pathophysi- ology, clinical features, diagnostic testing, and treatment of Wilson’s disease. KEYWORDS: Ceruloplasmin, copper, Wilson’s disease, penicillamine, zinc Although he was not the first to recognize the EPIDEMIOLOGY disease process,1 in a doctoral thesis of more than 200 Wilson’s disease is a rare autosomal-recessive disorder. A pages published in Brain in 1912, S. A. Kinnier Wilson prevalence rate of 30 cases per million (or one per masterfully provided the first detailed, coherent descrip- 30,000) and a birth incidence rate of one per 30,000 to 12–15 tion of both the clinical and pathological details of the 40,000 are often quoted. It has been estimated that entity that now bears his name.2 Many other individuals there are 600 cases of Wilson’s disease in the United 14 have embellished and expanded our understanding of States and that 1% of the population are carriers.
    [Show full text]